Earnings Preannouncement for 2025
Filed with SSE · · 2 pages · Chinese
Shandong Buchang Pharmaceuticals Co., Ltd. on 6ix
Earlier from Shandong Buchang Pharmaceuticals
- Announcement on the Plan of Share Repurchase through Call Auction and Obtaining of Commitment Letter on Special Loan for Repurchase from Financial Institution
- Announcement on Holding Subsidiary Completing Industrial and Commercial Change Registration
- Indicative Announcement on Changes in Fair Value of Trading Financial Assets
- Announcement on the Recognition of Wholly-owned Subsidiary as a High-tech Enterprise Again
- Announcement on Pledge of Controlling Shareholders' Shares
Later from Shandong Buchang Pharmaceuticals
- Announcement on Wholly-owned Subsidiary Completing Industrial and Commercial Change Registration
- Announcement on Progress in Proposed Waiver of Preemptive Rights for Equity of Holding Subsidiary and Related Party Transactions
- Announcement on Resolutions of the 43rd Meeting of the 5th Board of Directors
- Announcement on Pledge Release and Re-pledge of Partial Shares Held by Controlling Shareholder
- Announcement on Partial Drugs of the Subsidiary Being Selected for National Procurement Continuation After the Expiry of Agreement
Follow Shandong Buchang Pharmaceuticals into a list and get an email when it puts out news.
Follow Shandong Buchang Pharmaceuticals